Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes - Aso_2020_Am.J.Med.Sci_360_261 |
| Author(s) : Aso Y , Kase M , Sagara M , Sakurai S , Iijima T , Tomaru T , Jojima T , Usui I |
| Ref : American Journal of Medicine Sci , 360 :261 , 2020 |
| Abstract : Aso_2020_Am.J.Med.Sci_360_261 |
| ESTHER : Aso_2020_Am.J.Med.Sci_360_261 |
| PubMedSearch : Aso_2020_Am.J.Med.Sci_360_261 |
| PubMedID: 32540146 |
| Title : Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes - Jojima_2016_Diabetol.Metab.Syndr_8_45 |
| Author(s) : Jojima T , Tomotsune T , Iijima T , Akimoto K , Suzuki K , Aso Y |
| Ref : Diabetol Metab Syndr , 8 :45 , 2016 |
| Abstract : Jojima_2016_Diabetol.Metab.Syndr_8_45 |
| ESTHER : Jojima_2016_Diabetol.Metab.Syndr_8_45 |
| PubMedSearch : Jojima_2016_Diabetol.Metab.Syndr_8_45 |
| PubMedID: 27462372 |